Table of Contents
Lung Cancer International
Volume 2011, Article ID 152125, 4 pages
http://dx.doi.org/10.4061/2011/152125
Research Article

Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients: Patient Characteristics and Type of Chemotherapy

Clinical Oncology Department, King Hussein Cancer Center, Queen Rania Al-Abdullah Street, Al-Jubeiha, Amman 11941, Jordan

Received 29 September 2010; Accepted 24 November 2010

Academic Editor: Kaoru Kubota

Copyright © 2011 Salah Abbasi and Ahmed Badheeb. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. Rapp, J. L. Pater, and J. L. Pater, “Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer—report of a Canadian multicenter randomized trial,” Journal of Clinical Oncology, vol. 6, no. 4, pp. 633–641, 1988. View at Google Scholar · View at Scopus
  3. Non-Small Cell Lung Cancer Collaborative Group, “Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials,” British Medical Journal, vol. 311, no. 7010, pp. 899–909, 1995. View at Google Scholar
  4. J. H. Schiller, D. Harrington, and D. Harrington, “Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer,” New England Journal of Medicine, vol. 346, no. 2, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. Fossella, J. R. Pereira, and J. R. Pereira, “Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group,” Journal of Clinical Oncology, vol. 21, no. 16, pp. 3016–3024, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. O. Ademuyiwa, C. S. Johnson, A. S. White, T. E. Breen, J. Harvey, M. Neubauer, and N. H. Hanna, “Prognostic factors in stage III non-small-cell lung cancer,” Clinical Lung Cancer, vol. 8, no. 8, pp. 478–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. H. Sobin, C. Wittekind, and International Union Against Cancer (UICC), TNM Classification of Malignant Tumors, Wiley-Liss, New York, NY, USA, 6th edition, 2002.
  8. M. A. Socinski, D. E. Morris, G. A. Masters, and R. Lilenbaum, “Chemotherapeutic management of stage IV non-small cell lung cancer,” Chest, vol. 123, supplement 1, pp. 226S–243S, 2003. View at Google Scholar · View at Scopus
  9. K. S. Albain, J. J. Crowley, M. LeBlanc, and R. B. Livingston, “Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience,” Journal of Clinical Oncology, vol. 9, no. 9, pp. 1618–1626, 1991. View at Google Scholar · View at Scopus
  10. K. E. Stanley, “Prognostic factors for survival in patients with inoperable lung cancer,” Journal of the National Cancer Institute, vol. 65, no. 1, pp. 25–32, 1980. View at Google Scholar · View at Scopus
  11. D. M. Finkelstein, D. S. Ettinger, and J. C. Ruckdeschel, “Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group study,” Journal of Clinical Oncology, vol. 4, no. 5, pp. 702–709, 1986. View at Google Scholar · View at Scopus
  12. G. M. M. Videtic, L. W. Stitt, and L. W. Stitt, “Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival,” Journal of Clinical Oncology, vol. 21, no. 8, pp. 1544–1549, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. P. D. Bonomi, D. M. Finkelstein, and D. M. Finkelstein, “Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group,” Journal of Clinical Oncology, vol. 7, no. 11, pp. 1602–1613, 1989. View at Google Scholar · View at Scopus
  14. J. Klastersky, J. P. Sculier, and J. P. Sculier, “Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 7, no. 8, pp. 1087–1092, 1989. View at Google Scholar · View at Scopus